MedPath

Medical Nutrition Therapy Intervention Program for Women With Gestational Diabetes--a Prospective Study

Not Applicable
Conditions
Diabetes, Gestational
Interventions
Behavioral: Individualized medical nutrition therapy
Registration Number
NCT02893072
Lead Sponsor
The Third Xiangya Hospital of Central South University
Brief Summary

Gestational diabetes mellitus (GDM) is one of the most frequent complications of pregnancy, that affect between 1 to 14% of population around the world. The overall purpose of this study is to determine the efficacy of individualized medical nutrition therapy (MNT) intervention to reduce and control the development of GDM.

Detailed Description

The number of women with gestational diabetes mellitus had been increasing. Maternal GDM has a great impact on both the health of the mothers and the offspring. Antenatal lifestyle interventions, in particular dietary intervention appear to be feasible to improve maternal GDM and weight gain. To the best of our knowledge, there has been no such trial examining the feasibility of MNT intervention in pregnant women in Hu'nan province. The aim of this study is to evaluate the efficacy of individualized MNT intervention to reduce and control the development of GDM. This is a prospective study, 500 patients who meet inclusion and exclusion criteria will be included. The changes of glucose and weight will be evaluated every two weeks.

Recruitment & Eligibility

Status
UNKNOWN
Sex
Female
Target Recruitment
600
Inclusion Criteria
  • Women with gestational diabetes
Exclusion Criteria
  • None

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Individualized medical nutrition therapyIndividualized medical nutrition therapyA comparison of normal lifestyle and medical nutrition therapy after intervention in the same individual
Primary Outcome Measures
NameTimeMethod
intravenous glucoseevery two weeks, from date of randomization until the date of parturition, assessed up to 10 months

Investigators will measure the participants' intravenous glucose every two weeks.From date of randomization until the date of parturition,assessed up to 10 months.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

the Third Xiangya Hospital of Central South University

🇨🇳

Changsha, Hunan, China

© Copyright 2025. All Rights Reserved by MedPath